Physician profile
Patrick N Capri
NPI 1841357951
$989.37
in general payments reported to CMS, 2019-2025
14 companies · $380 in 2025
The $380 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2023: $108 · 2024: $169 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $657.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $162.56 | 2019-2025 | Ozempic, Rybelsus |
| Amgen INC. | $153.22 | 2024-2025 | Repatha, Repatha, Otezla |
| Pfizer INC. | $112.46 | 2019-2025 | |
| Exact Sciences Corporation | $105.28 | 2023-2025 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $70.55 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $70.40 | 2023-2025 | Xifaxan |
| Janssen Pharmaceuticals, INC | $66.03 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $52.15 | 2024 | |
| Lilly USA, LLC | $51.44 | 2024-2025 | Mounjaro, Zepbound |
| Dexcom, INC. | $47.93 | 2025 | Dexcom G6 Transmitter |
| Lucid Diagnostics INC. | $30.64 | 2023 | |
| Abbott Laboratories | $24.87 | 2025 | Freestyle Libre 3 |
| Si-Bone, INC. | $22.98 | 2025 | |
| Philips North America LLC | $18.86 | 2024 | (Ck7) Extended Holter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Capri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.